This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milan, G. Articles by Vettor, R. Search for Related Content PubMed PubMed Citation Articles by Milan, G. Articles by Vettor, R.

Changes in Muscle Myostatin Expression in Obese Subjects after Weight Loss

Department of Medical and Surgical Sciences (G.M., C.Pi., C.Pa., M.G., R.V.), University of Padova Italy; Department of Medicine (G.M., M.M.), Catholic University S. Cuore, Rome, Italy; and Department of Clinical and Experimental Medicine (E.D.N.), University of Ferrara, Italy

Address all correspondence and requests for reprints to: Roberto Vettor, M.D., Institute of Semeiotica Medica, University of Padua, via Ospedale 105, Padua 35128, Italy. E-mail: roberto.vettor{at}unipd.it.

Abstract

Myostatin is a member of transforming growth factor-ß superfamily that plays an important inhibitory role during muscle development; in fact mutations of myostatin gene result in a hypermuscular phenotype. Moreover myostatin-deficient mice have a significant reduction in fat depots and a depression of adipogenesis. Little is known about myostatin function in muscle growth regulation in humans and in particular during caloric restriction. In the present work we quantified by real-time RT-PCR myostatin expression in muscle biopsies of a group of morbidly obese patients before and after weight loss obtained by biliopancreatic diversion (BPD). The patients reduced body weight by 38.9%, mostly due to fat-mass loss, showing also a significant reduction in the 24-hour EE as assessed by the respiratory chamber. Myostatin mRNA levels result clearly decreased after weight loss, suggesting a role in counteracting the progressive decline of muscle mass after BPD. Myostatin may provide therefore another mechanistic explanation for the control of energy partitioning between protein and fat, working against muscle wasting. Our data suggest that myostatin might represent an important regulator of skeletal muscle size also in conditions of food restriction in obese subjects.

This article has been cited by other articles:

				C. Pagano, C. Pilon, A. Calcagno, R. Urbanet, M. Rossato, G. Milan, K. Bianchi, R. Rizzuto, P. Bernante, G. Federspil, et al. The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4810 - 4819. [Abstract] [Full Text] [PDF]

				M. Castro-Gago, C. Gomez-Lado, J. Eiris-Punal, I. Carneiro, V. M. Arce, and J. Devesa Muscle Myostatin Expression in Children With Muscle Diseases J Child Neurol, January 1, 2007; 22(1): 38 - 40. [Abstract] [PDF]

				J.-J. Park, J. R. Berggren, M. W. Hulver, J. A Houmard, and E. P. Hoffman GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle Physiol Genomics, October 11, 2006; 27(2): 114 - 121. [Abstract] [Full Text] [PDF]